WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 31-May-2017 (data as of 23-May-2017)
Next overall update Jul-2017
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 6301 Infant (under 12 months) mortality rate: 2
GDP / capita (US$): 1'9341 Child (under 5 years) mortality rate: 2

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 33'370  32'527  31'628  30'683  29'727  20'531  12'068  13'211 
Births 1'082  1'081  1'081  1'083  1'087  1'000  627  646 
Surviving infants 1'011  1'008  1'007  1'007  1'009  908  551  536 
Pop. less than 5 years 4'925  4'950  4'967  4'994  5'019  4'100  2'340  2'475 
Pop. less than 15 years 14'455  14'325  14'192  14'017  13'808  9'959  5'800  6'071 
Female 15-49 years 7'681  7'383  7'071  6'758  6'456  4'252  2'599  2'920 

Number of reported cases

(Click for retrospective incidence data for Afghanistan)
Diphtheria
ChartChart
  84  368  1'939 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  638  1'154  492  430  2'787  6'532  1'609  32'455 
Mumps
ChartChart
  29 
Pertussis
ChartChart
  432  371  1'497  896  411  15'748 
Polio*
ChartChart
  13  20  28  17  46  120  48  880 
Rubella
ChartChart
  42  59  43  367 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  12  17  13  21  139  16 
Tetanus (total)**
ChartChart
  74  39  24  37  131  1'618 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Afghanistan)
Vaccine year result method % card seen                                                
BCG 2014  74  DHS   56  87  97  97  89  89  30  30  33 
DTP1 2014  73  DHS   56  92  99*  99*  98  99*  48 
DTP3 2014  58  DHS   56  81  98  95  90  87  24  25 
DTP4          93 
IPV1          81 
HepB_BD          20  18 
HepB3 2014  58  DHS   56  81  98  95  90  87 
Hib3 2014  58  DHS   56  81  98  95  90  87 
JapEnc         
MCV1          75  90  88  82  81  27  20  11 
MCV2          51  60  60  56  54 
PCV1          86  99*  99* 
PCV3 2014  45  DHS   56  77  89  63 
Pol3 2014  65  DHS   56  81  97  90  90  87  24  25 
Rota1         
RotaC         
RCV1         
TT2plus 2011  35       58  91  85  63  76  20 
PAB         
VAD1          15 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Afghanistan)
BCG
ChartChart
  86  86  78  78  30  30 
DTP1
ChartChart
  82  82  80  78  48  50  22 
DTP3
ChartChart
  78  75  70  67  24  25 
HepB3
ChartChart
  78  75  70  67 
HepB_BD
ChartChart
  18 
Hib3
ChartChart
  78  75  70  67 
IPV1
 
MCV1
ChartChart
  68  66  60  59  27  20  11 
MCV2
ChartChart
  39  39  35  33 
PAB
ChartChart
  70  70  65  60  32  13 
PCV3
ChartChart
  66  40 
Pol3
ChartChart
  77  75  70  67  24  25 
RCV1
ChartChart
 
RotaC
ChartChart
 

Number of districts in the country 356  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 34
From 80 to 89% 9
From 50 to 79% 32
Less than 50% 25
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB birth; No
IPV 14 weeks; Yes
Measles 9, 18 months; Yes
MR Yes From June 2018
OPV birth; 6, 10, 14 weeks; 9 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus Yes From September 2017
TT 1st contact; +1, +6 months; +1, +1 year; Yes CBAW

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2019  2015-2019  2015-2019  2011-2015  2011-2015  2011-2015  2010-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 80  61  321  321  321  321 

System performance

Total Nº districts in country number 356  329  329  329  329  329  329 
Nº districts with DTP3 coverage >=80% number 155  206  224  219  195  187  190 
% of districts with DTP3 coverage >=80% From 0 to 100% 44  63  68  67  59  57  58 
Nº districts with measles (MCV1) coverage >=95% number 84  121  145  136  111  99  93 
% of districts with MCV1 coverage >=95% From 0 to 100% 24  37  44  41  34  30  28 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No  No  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  No  No  No  No   

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%          

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2016 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.